Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mills

Showing results (1031-1040 of 1,298) with videos related to

Pageof 130
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2014
Influence of biospecimen variables on proteomic biomarkers in breast cancerFunda Meric-Bernstam, Argun Akcakanat, Huiqin Chen, et al.
Analytical Chemistry|August 8, 2017
An LC-MS/MS-Based Method for the Quantification of Pyridox(am)ine 5'-Phosphate Oxidase Activity in Dried Blood Spots from Patients with EpilepsyMatthew P Wilson, Emma J Footitt, Apostolos Papandreou, et al.
Oncotarget|April 2, 2016
The degree of intratumor mutational heterogeneity varies by primary tumor sub-siteLevi G Ledgerwood, Dhruv Kumar, Agda Karina Eterovic, et al.
Journal of the National Cancer Institute|January 2, 2017
Role of RPL39 in Metaplastic Breast CancerBhuvanesh Dave, Daniel D Gonzalez, Zhi-Bin Liu, et al.
The Journal of Clinical Investigation|November 18, 2014
LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancerLuis J Schwarz, Emily M Fox, Justin M Balko, et al.
Cancer Cell|March 12, 2015
Regulation of glutamine carrier proteins by RNF5 determines breast cancer response to ER stress-inducing chemotherapiesYoung Joo Jeon, Sihem Khelifa, Boris Ratnikov, et al.
Chemmedchem|April 6, 2011
Benzyl and naphthalene methylphosphonic acid inhibitors of autotaxin with anti-invasive and anti-metastatic activityRenuka Gupte, Renukadevi Patil, Jianxiong Liu, et al.
Nature Communications|July 26, 2020
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer modelsHyoung Kim, Haineng Xu, Erin George, et al.
EMBO Molecular Medicine|December 28, 2020
Beclin-1-mediated activation of autophagy improves proximal and distal urea cycle disordersLeandro R Soria, Sonam Gurung, Giulia De Sabbata, et al.
Oncogene|July 25, 2021
Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanomaBeike Wang, Wei Zhang, Gao Zhang, et al.
Pageof 130

Showing results (1031-1040 of 1,298) with videos related to

Sort By:
Pageof 130
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2014
Influence of biospecimen variables on proteomic biomarkers in breast cancerFunda Meric-Bernstam, Argun Akcakanat, Huiqin Chen, et al.
Analytical Chemistry|August 8, 2017
An LC-MS/MS-Based Method for the Quantification of Pyridox(am)ine 5'-Phosphate Oxidase Activity in Dried Blood Spots from Patients with EpilepsyMatthew P Wilson, Emma J Footitt, Apostolos Papandreou, et al.
Oncotarget|April 2, 2016
The degree of intratumor mutational heterogeneity varies by primary tumor sub-siteLevi G Ledgerwood, Dhruv Kumar, Agda Karina Eterovic, et al.
Journal of the National Cancer Institute|January 2, 2017
Role of RPL39 in Metaplastic Breast CancerBhuvanesh Dave, Daniel D Gonzalez, Zhi-Bin Liu, et al.
The Journal of Clinical Investigation|November 18, 2014
LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancerLuis J Schwarz, Emily M Fox, Justin M Balko, et al.
Cancer Cell|March 12, 2015
Regulation of glutamine carrier proteins by RNF5 determines breast cancer response to ER stress-inducing chemotherapiesYoung Joo Jeon, Sihem Khelifa, Boris Ratnikov, et al.
Chemmedchem|April 6, 2011
Benzyl and naphthalene methylphosphonic acid inhibitors of autotaxin with anti-invasive and anti-metastatic activityRenuka Gupte, Renukadevi Patil, Jianxiong Liu, et al.
Nature Communications|July 26, 2020
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer modelsHyoung Kim, Haineng Xu, Erin George, et al.
EMBO Molecular Medicine|December 28, 2020
Beclin-1-mediated activation of autophagy improves proximal and distal urea cycle disordersLeandro R Soria, Sonam Gurung, Giulia De Sabbata, et al.
Oncogene|July 25, 2021
Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanomaBeike Wang, Wei Zhang, Gao Zhang, et al.
Pageof 130